Objectives-This is the first systematic review of the effectiveness of barcoding practices for reducing patient specimen and laboratory testing identification errors.
Introduction
Reduction of medical errors has been a major national priority since the publication of the Institute of Medicine report To Err is Human [1] . Patient specimen and laboratory testing identification errors have been reported as the leading cause of laboratory errors [2] . Identification (ID) errors may result in patient harm and are completely preventable. Identifying effective strategies for reducing these errors has been identified as a research priority [3] , but there are no systematic reviews available providing evidence of effectiveness for quality improvement practices. The purpose of this article is to provide a systematic review that evaluates whether barcoding practices are effective at reducing patient specimen and laboratory testing identification errors. The answer is provided by applying the CDC Laboratory Medicine Best Practices Initiative's (LMBP) systematic review methods for quality improvement practices and translating the results into evidence-based guidance [4] .
Accurate identification of patients, their specimens and laboratory test results linked to them is essential in all healthcare settings for providing effective, safe, timely, efficient, equitable and patient-centered healthcare. Systems to monitor errors in patient specimen and laboratory testing identification are federally regulated [5] , and accurate identification is a nationally recognized patient safety priority [6] [7] [8] [9] [10] [11] . Although government, accreditation, patient safety, professional and industry organizations require laboratories to establish and follow policies and procedures to ensure accurate identification from specimen collection to result reporting, the guidance provided is largely based on expert opinion. Typical hospital clinical laboratories are responsible for thousands of tests daily, yet there is considerable uncertainty about how to reduce identification errors, and what quality improvement practices are effective [12] . ID error consequences include incorrect, delayed and/or lack of treatment which may cause injury, disability, death, longer lengths of stay, and higher healthcare costs, as well as other patient harm and diverted resources [13] [14] [15] . Accurate identification is particularly essential to the safe transfusion of blood products since ID errors put patients at risk for adverse outcomes from blood incompatibility [14] .
Quality Gap: Patient Specimen and Laboratory Testing Identification Errors
ID errors involve incorrect matching of patient, specimen and/or test information, all of which should be unequivocally linked to a correct patient identify throughout the entire testing process [7, 13] . There are many causes of ID errors, most of which are associated with human error and under the control of the laboratory [13] . ID errors lack a standardized definition a and systems for detecting, reporting, measuring and categorizing them and their consequences among laboratories and health care organizations. They are generally considered underreported as the true frequency includes undetected errors [8, 11] . As a consequence, reported ID error results can vary among organizations due to differences in measurement methods and how effective laboratory and clinical staff are in identifying errors [8, 9] , which makes it difficult to arrive at conclusions about the true size and variability of the ID error quality gap.
Reported ID error rates of 1% and less are common [3, 10, [16] [17] [18] [19] [20] ], yet are still considered a serious problem since any error has the potential for serious adverse patient consequences. The lowest rates are associated with transfusion medicine and are usually less than 0.1%, followed by the general pathology laboratory at closer to 1%, but as high as 10% [21] [22] [23] [24] [25] [26] , with even higher rates found in surgical pathology [8, 13, 27 ]. While errors rates at or very close to 0% have been documented, the upper end of the range could be as high as 50%. The highest rates [23, 27] have been measured by a prospective, direct observation method using surgical specimen requisitions and container labeling with an extensive list of variables included in the ID error definition. Most detected errors do not harm patients since their detection results in the associated erroneous test reports typically not being released by the laboratory [8, 9, 28 ].
Methods
This evidence review followed the "A-6 Cycle" systematic review methods for evaluating quality improvement practices funded by the CDC's Laboratory Medicine Best Practices Initiative (LMBP) and reported in detail elsewhere [4] . This approach is derived from previously validated methods, and designed to transparently evaluate the results of studies of practice effectiveness to support evidence-based best practice recommendations. A review team conducts the systematic review and includes a review coordinator and staff trained to apply the LMBP methods. Guidance is provided by a multi-disciplinary expert panel including at least one LMBP Workgroup member and individuals selected for their diverse perspectives as well as relevant expertise in the topic area, laboratory management, and evidence review methods. b The results are translated into an evidence-based best practice recommendation by the expert panel for approval by the LMBP Workgroup. These methods as applied in this evidence review of barcoding practices are presented below.
ASK: Review question and analytic framework
The LMBP methods begin with the ASK step which frames at least one review question supported by an analytic framework and PICO elements (population, intervention/practice, comparator, outcome). The question answered by this evidence review is:
Are barcoding practices effective at reducing patient specimen and laboratory testing identification errors?-This review question is addressed in the context of an analytic framework for the quality issue of patient specimen and laboratory testing identification errors (Figure 1 ). The relevant PICO elements are:
• Population: all patients in healthcare settings using laboratory or point-of-care testing and their specimens requiring accurate identification for use in a healthcare context
• Intervention: barcoding practices defined as laboratory test barcoding systems using barcoded patient identification linked to specimen labels or point-of-care testing
• Comparison practice/intervention: non-barcoded identification systems for patients, specimens and laboratory tests
• Outcome: specimen and/or laboratory testing identification error rates are the primary and most direct outcome of interest.
The two barcoding practices being evaluated in this review are described below.
Barcoding Systems: Electronic barcoding for identification of patients, specimens and laboratory testing is used to positively establish identification and link specimens and tests to a patient throughout the entire testing process including test ordering, specimen collection, analysis and test result reporting [13] . Barcode scanners are used to confirm patient identity. Other options include barcoded patient wristbands, portable printers to generate labels at the bedside, and use of an interface with a computerized physician order entry (CPOE) system.
Point-of-Care Test Barcoding Systems:
Automated patient specimen and laboratory testing identification system use bar-coded patient identification and bar code scanners with a testing device at or close to the patient. Testing devices can interface with laboratory information systems to receive and transmit patient identification and test result information. This practice may include barcoded patient wristbands.
ACQUIRE: Search for practice effectiveness evidence
The search for studies of barcoding practice effectiveness to reduce patient specimen and laboratory testing ID errors included a systematic search of multiple electronic databases, hand searching of bibliographies from relevant information sources and their bibliographies, provision of references by as well as consultation with experts in the field including members of the expert panel (Appendix A). Additional evidence was obtained by solicitation of unpublished quality improvement studies resulting in submissions to the Laboratory Medicine Best Practices Initiative. c The literature search strategy and terms were developed with the assistance of a research librarian and included a systematic search in August 2011 of three electronic databases (PubMed, Embase and CINAHL) for English language articles from 1995 to 2012 about human subjects. The search contained the following Medical Subject Headings: automatic data processing, blood transfusion, hospitals, laboratories, methods, patient identification systems, patients, and specimen handling as well as these keywords: barcode/bar-code/bar code, labeling errors, laboratory/ ies, methods/strategy(ies) reduce patient specimen handling practice/identification errors, patient identification systems errors, pharmaceutical, specimen, and transfusion.
APPRAISE: Screen and evaluate evidence
The ACQUIRE step search results are reviewed by an initial screening of titles and abstracts using pre-specified inclusion criteria consistent with the ASK step, followed by a full-text review of all eligible effectiveness studies, involving abstracting, standardizing and evaluating study quality using the LMBP methods. Included studies are considered to provide valid and useful information addressing the review question [29] with barcoding effectiveness findings that include at least one ID error outcome measure. To reduce subjectivity and the potential for bias, all screening, abstraction and evaluation is conducted by at least two independent reviewers, and all reviewer discrepancies are resolved through consensus. The effect size for each study was standardized using its reported data and results to calculate an odds ratio (OR) d since the outcome of interest is dichotomous (i.e., correctly identified versus misidentified) and the findings for these practices are typically expressed in terms of rates or percentages. The OR compares the barcoding practice to a non-barcoding practice in terms of the relative odds of a successful outcome (i.e., the patient's specimen and/or test is correctly identified versus incorrectly identified). Each study is assigned one of three quality ratings (Good, Fair, Poor) and one of three effect size ratings (Substantial, Moderate or Minimal/none). e
ANALYZE: Evidence review synthesis and results
The individual effectiveness study results from the APPRAISE step are aggregated into two practice-specific bodies of evidence (barcoding systems and POCT barcoding) and then analyzed to produce the systematic review practice effectiveness results for translation into evidence-based recommendations (Recommend, No recommendation for or against, Recommend against). Both qualitative and quantitative analyses are used to assess effect size consistency and patterns of results across studies [30] . Qualitative analysis is used to rate the overall strength of the body of evidence for practice effectiveness (High, Moderate, Suggestive, or Insufficient) Criteria for these ratings are described in detail elsewhere [4, 31] . The qualitative analysis synthesizes the individual studies to convey key study characteristics, results and evaluation findings summarized in a body of evidence table. A quantitative analysis is provided using meta-analysis of the results from similar individual studies to estimate a weighted average effect size and confidence interval using a randomeffects model f with the results presented in a forest plot.
Evidence review synthesis and results
The ACQUIRE step procedures identified 1,307 separate bibliographic records that were screened for eligibility to contribute evidence of the relation of barcoding with ID error outcomes. The APPRAISE step screening resulted in 1,211 of these records being excluded as off-topic, and 73 being excluded for not meeting effectiveness study inclusion criteria (i.e., not a study, no barcoding practice, no ID error outcome measure) for a total of 23 fulltext studies meeting the review inclusion criteria. A systematic review flow diagram in Figure 2 provides a breakdown of the search results. Abstracted and standardized information as well as study quality ratings for the 23 eligible studies are provided in Appendix B containing evidence summary tables preceded by a Body of Evidence table for d See Glossary for more information on odds ratios. e The criteria for a Substantial effect size rating: OR > 2.0 and significantly different from OR =1.0 at p = 0.05 (i.e., the lower limit of the 95 percent confidence interval is > 1.0). f Random-effects model assumes there is no common population effect size for the included studies and the studies' effect size variation follows a distribution with the studies representing a random sample. This is in contrast to the fixed-effects model which assumes a single population effect size for all studies and that observed differences reflect random variation.
each practice. Bibliographic reference information for these studies is provided in Appendix C.
The full-text review and evaluation of the 23 eligible studies resulted in the exclusion of 6 studies due to "poor" study quality ratings which did not meet the minimum required LMBP study quality inclusion criteria (4 barcoding systems studies: 3 published and 1 unpublished; 2 point-of-care test barcoding studies: 1 published and 1unpublished). A total of 17 studies are included in this review as evidence of practice effectiveness (8 of which are unpublished submissions): 10 studies for barcoding systems (3 unpublished) and 7 studies for point-ofcare test barcoding (5 unpublished). All included studies used observational before-after study designs.
Barcoding systems practice effectiveness evidence
Of the 10 studies included in the barcoding systems practice body of evidence, 7 were published and 3 were unpublished, and 6 were rated "Good" study quality and 4 were rated "Fair" with summarized information provided in Table 1 . The earliest study time period was 1999-2000, and the starting date for 6 of the studies was 2005 or later, with 3 published in 2010. All study sample sizes were very large while the number of identification errors was very small. In all studies both the barcoding and the non-barcoding comparison groups were considerably in excess of 1,000 specimens. All but 2 studies exceeded 10,000 specimens for both groups, and 3 studies exceeded 100,000 specimens. All 10 included studies involved laboratory testing with identification of patient specimens using labels in U.S. hospital settings; 8 studies from clinical pathology laboratories and 2 from surgical/anatomic pathology laboratories (Zarbo 2009 and University of Washington 2009). There was geographic and patient diversity across study settings which included inpatient, outpatient, emergency department and pediatric settings. All hospitals were relatively large, with the smallest exceeding 200 beds. Four studies relied exclusively on inpatient blood specimens and used bedside label printing (Brown 2010 Table 1 , the evidence of practice effectiveness for reducing ID errors indicates consistent improvement associated with barcoding systems compared to non-barcoding practices with a high strength of evidence in hospital settings. The odds ratio for 9 of the 10 barcoding system studies exceeded 2.0 (favoring barcoding), and the 95% confidence interval lower limit exceeded 1.0 for 8 of the 10 studies. The 3 study exceptions , Morrison 2010 , and LBJ 2009 had the smallest numbers of ID errors in the barcoding and non-barcoding study groups ranging from 0 to 12 which corresponded to very large sample sizes; the smallest being about 25,000 and the rest substantially larger. The odds ratio estimates for all 10 included studies ranged from 1.7 to 147. The unpublished studies' odds ratios were consistent with those of the published studies with the exception of the uppermost unpublished study odds ratio of 147. Figure 3 presents the meta-analysis effect size results for barcoding systems. The odds ratio for each of the 9 included studies favors the barcoding system practice over the non-barcoding practice for improving identification error rates indicating a consistent and statistically significant effect. The overall summary effect mean odds ratio was 4.39 (95% CI: 3.05 -6.32). The higher rated "Good" study quality subgroup summary effect size exceeded that of the lower rated "Fair" quality subgroup with an odds ratio of 5.14 versus 2.43. The lower limit of the confidence interval for both subgroups exceeded 1.0 at 3.41 for the 6 "Good" quality studies but only 1.1 for the 3 "Fair" studies. One of the ten barcoding system practice effectiveness studies was excluded from the meta-analysis (University of Washington 2009) as its ID error rate outcome measure (processed specimen cassettes/blocks rather than specimens in their original containers with labels) and results (OR = 147; 95% CI: 55 -391) were considered too heterogeneous relative to the other nine included studies.
Body of evidence qualitative analysis-As summarized in
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Meta-analysis results for barcoding systems show significant statistical heterogeneity which is typical of random effects results. The I 2 statistic ranges from 0-100% and estimates the percent of variability in estimates attributable to between study differences. Studies rated "Good" showed somewhat less between-study variation (10.5%) relative to "Fair" studies (15.9%) which had larger estimated odds ratios. This modest attenuation of effect size from "Fair" studies contributes to modest between-study variation (24.8%) in the overall estimate.
Point-of-care test barcoding practice effectiveness evidence
Of the 7 studies included in the point-of-care barcoding practice effectiveness body of evidence, 2 were published and 5 were unpublished, and 5 were rated "Good" study quality and 2 were rated "Fair" with summarized information provided in Table 2 . All of the included studies relied on U.S. hospital inpatient point-of-care glucose tests, with at least 4 studies also including emergency department patient tests. The earliest study time period began at the end of 2002, while the remaining studies began in 2006 or later, with 4 ending in 2011. Like the barcoding systems' practice effectiveness studies, the point-of-care test barcoding study sample sizes were typically very large with all barcoding and nonbarcoding groups exceeding 10,000 tests with one exception . Several studies had barcoding and/or comparison groups with substantially more than 100,000 tests. Four of the unpublished studies came from separate hospitals within one hospital system (Catholic Health System: Kenmore Mercy Hospital, Mercy Hospital of Buffalo, Sisters of Charity Hospital Buffalo and Sisters of Charity Hospital St. Joseph Campus). As a result, the body of evidence is not as geographically diverse as for barcoding systems, but the study settings may be reasonably representative of diverse hospitalized patient populations. Table 2 , the evidence of practice effectiveness for reducing identification errors indicates consistent and substantial improvement for point-of-care test barcoding compared to non-barcoding (manual entry) practices with a high strength of evidence for point-of-care glucose testing in hospital settings. The point-of-care barcoding practice odds ratio for all 7 of the included studies exceeded 2.0 (favoring the barcoding practice over non-barcoding practices), and the lower limit of the odds ratios' 95% confidence interval exceeded 1.0 for 6 of the 7 studies. The one study exception had the smallest numbers of errors (4 without barcoding; 0 with barcoding) and the smallest total sample size (462) of the included studies. The odds ratio estimates for all the included studies ranged from 3.76 to 14.72. Figure 4 presents the meta-analysis results for the point-of-care test barcoding practice. The overall summary effect mean odds ratio was 5.93 (95% CI: 5.28 -6.67). The 5 higher rated "Good" quality studies' subgroup summary effect size was similar: mean odds ratio of 5.83 (95% CI: 3.86 -8.82). Of the 7 included studies, only one had an odds ratio 95% confidence interval lower limit less than 1.0 , reflecting the very small number of identification errors in the study (4) as well as a relatively small sample size (462). These meta-analysis results show significant statistical heterogeneity as is typical of random effects results. Most of the point-of-care test barcoding meta-analysis results' statistical heterogeneity is attributable to within-study variance. The higher rated "Good" study quality subgroup showed modest between-study variation (I 2 = 27.8%) while all between-study variation in the fair and overall results can be attributed to chance. At the aggregate level, results for "Fair" and "Good" studies are essentially indistinguishable and can be considered well represented by the overall mean estimate. 
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Discussion
Additional benefits-
The studies reviewed report other beneficial outcomes associated with barcoding including an observed reduction in misidentified patients [40] , unnecessary phlebotomy [40] , labor time savings and reduced workflow process time in surgical pathology [32, 33] . Implementing barcoding has been credited with improving identification of those responsible for making ID errors, thus enabling targeted measures to improve performance [37, 40] . Cost savings noted from fewer ID errors associated with barcoding include reductions in specimen recollections, labor to investigate and correct ID errors, length of patient stays and legal issues [41] . Additional benefits to patients from fewer ID errors include avoiding unnecessary discomfort, inconvenience, and treatment delays from recollecting and retesting specimens [40, 42] .
Economic evaluation-
No patient specimen barcoding practice economic evaluations (cost, cost-effectiveness, or cost-benefit analyses) were found in the search results described in section 2.2. g Completing a resource-related inventory for barcoding practices is beyond the scope of this study but it should include the costs associated with implementing and sustaining the practice (e.g., hardware, software, equipment, supplies and labor requirements as well as resources associated with training, testing, monitoring, and maintenance) and all downstream costs and savings that occur because the intervention was performed [43] .
Feasibility of implementation-
The evidence reviewed clearly demonstrates the feasibility of adopting barcoding practices in a variety of hospital settings. Nevertheless, each environment is distinctive and implementation requires adequate process development and modification, training, education and testing to achieve full effectiveness. Barcoding process design issues appear more complex for surgical pathology [32, 44] which typically involves more workflow process steps than patient specimens for routine laboratory or point-of-care testing. Many studies on surgical pathology describe the approach used for barcoding-related process changes in detail, along with the accompanying challenges and solutions [32, 36-38, 40, 42, 45] . Key implementation components for making barcoding technology work as intended include adequate training and education, well-designed patient ID bands, and adequate supplies and equipment maintained in good working order (e.g., label printers, computers, batteries, wireless networks) [13] . Shortages and performance issues were noted as problems frustrating staff that can result in using error-prone work around processes [42] . Support and involvement from all relevant departments and leaders including nursing, laboratory and information systems, were identified as critical success factors since no one department typically has full ownership of implementing and using barcoding technology.
Future research needs
Standardized outcome measures and measurement methods that consistently and reliably detect ID errors are needed for robust evaluation and comparison of QI practices. For more complete and useful assessment of barcoding practices, studies are needed to address its applicability and effectiveness in ambulatory and non-hospital settings, as well as more research evaluating barcoding in surgical pathology and settings known to have relatively higher ID error rates (e.g., emergency departments). Cost-effectiveness studies evaluating investments in potentially expensive ID error reduction technologies such as barcoding are needed. There should be a focus on settings with greater potential ID error impact due to higher rates and/or more serious consequences. Addressing this requires well-constructed data collection and analysis efforts identifying and measuring resources needed for implementation and maintenance of barcoding along with outcomes of interest. Future effectiveness research can be more informative if expected barcoding effectiveness moderators including implementation variables or practice components (e.g., electronic order system interface, bedside labeling, different barcode formats) can be evaluated for their contribution to overall effectiveness. Other benefits and harms of barcoding for patient specimen identification have not been well studied or reported and may be unknown. More information on other potential practice effects is needed to evaluate the full range of consequences and to allow for a comprehensive assessment of its net benefit. In addition, more information is needed about how to maintain and enhance the effectiveness of barcoding over time.
Limitations
The LMBP systematic review methods are consistent with practice standards for systematic reviews [30] , but all such methods are imperfect and include subjective assessments at multiple points that may produce bias. Like most systematic reviews, this one may be subject to publication bias, although this review includes unpublished studies which may mitigate that bias. The restriction to English language studies to satisfy the requirement of multiple reviewers for each study may also introduce bias if barcoding practices differ substantially in international settings. Quality improvement efforts typically differ from research, and are commonly observational studies that rely on natural experiments in realistic practice settings. The major drawback of these uncontrolled designs is that it is not possible to know if measured or unmeasured factors affect the outcomes of interest. Regardless of study design, by gathering evidence from multiple clinical and organizational settings, systematic reviews provide more useful assessments of the totality of evidence for a given QI practice than individual studies [46] .
Barcoding and other technology or practice changes may be easier to measure than individual step process changes that may contribute to observed results. Also, these processes are rarely uniform, and are clearly very different for clinical versus surgical pathology specimens, and for point-of-care testing. While these factors may moderate study findings and the observed heterogeneity suggests they are not insignificant, it can be observed that all studies reported support for barcoding.
Some studies comprising the barcoding body of evidence involved less than full implementation for all or a portion of the post-implementation period which would have an expected tendency to understate the impact of barcoding on the reduction in ID error rates.
In particular, some studies indicated barcoding "scan rates" of substantially less than 100 percent during the post-implementation period such that the effect of a non-barcoding practice (i.e., manual entry of patient identification information) is reflected in a portion of the post-implementation data. This was noted when provided, however as it was not always clearly or consistently reported it could not be used to adjust effect size estimates. As studies were done within a single institution, there may be many site-specific differences that impact their study results. Many studies were missing information including actual study sample sizes, dates for relevant time periods, and practice implementation and setting characteristics. Another perceived limitation is the inclusion of unpublished studies.
Designing and publishing controlled studies are typically not among the primary objectives of individuals collecting and analyzing quality improvement data relevant to laboratory medicine. In the barcoding body of evidence, both the published and unpublished studies had similar limitations. The LMBP experience to date in reviewing and rating study quality for both published and unpublished studies indicates that peer-reviewed journals do not provide assurance of high study quality.
Conclusion and Recommendation
On the basis of a high overall strength of evidence of effectiveness, barcoding systems for specimen labeling and point-of-care test barcoding are recommended as best practices to reduce identification errors and improve the accuracy of patient specimen and laboratory testing identification in hospital settings. The high overall strength of evidence is due to sufficient evidence of practice effectiveness from individual studies demonstrating consistent and substantial reduction in patient specimen and laboratory testing-related identification error rates in hospital settings. The findings of barcoding effectiveness are based on 10 studies of specimen barcoding systems and 7 studies of point-of-care test barcoding assessing impact on identification errors. In every study barcoding is associated with a reduction in the identification error rate. The meta-analysis overall summary effect mean odds ratio favoring barcoding is 4.39 (95% confidence interval: 3.05 -6.32) for barcoding systems and 5.93 (95% confidence interval: 5.28 -6.67) for point-of-care test barcoding. There was limited evidence of additional benefits and potential harms associated with the use of barcoding for specimen and laboratory testing identification, and any effect of potential harms appears to be very small relative to its overall benefits. All included studies were conducted in hospital settings. No evidence was available for assessing the effectiveness and applicability of barcoding in other laboratory testing settings. 
Acknowledgments
Consistency
The degree to which estimates of effect for specific outcomes are similar across included studies.
External validity
Generalizability, applicability -extent to which the effects observed in the study are applicable outside of the study to other populations and settings.
Effect size
A value which reflects the magnitude of the difference in a study's outcome measure between the group with the intervention/practice being evaluated and its control or comparison group.
ID errors
Misidentification in matching a patient or a specimen with a laboratory test. ID errors may include specimen/test requisition mismatches (e.g., specimen labeled with another patient's name, wrong type of specimen, duplicate orders or specimens), mislabeled specimens (sometimes referred to as "wrong blood in tube"), specimen label with partial, missing or incorrect information (e.g., one of two patient identifiers, missing or wrong patient gender, date of birth or middle initial), and unlabeled specimens. [9, 12] Different institutions may use different denominators when expressing ID errors as a rate (e.g., number of specimens, phlebotomies, requisitions, accessions). Some ID error types are more likely to be detected by the laboratory than others (e.g., mismatch versus wrong blood in tube), with those detected typically preventing the release of a test result. [8] Most ID errors are the result of human error, and causes include but are not limited to:
laboratory tests ordered on the wrong patient, incorrect or incomplete entry of patient data in the laboratory information system, collection of specimens from the wrong patient, inappropriate labeling of specimens, multiple users of the same label printer, lost identification label on specimens, incorrect identification information on specimen labels, pre-printed labels from different patients, handwritten labels on specimen containers, tissue cassettes and slides, and incorrect entry of patient results in the laboratory information system. [13] Internal validity extent to which the design and conduct of the study are likely to prevent systematic error. Internal validity is a prerequisite for external validity.
Meta-analysis
The process of using statistical methods to combine quantitatively the results of similar studies in an attempt to allow inferences to be made from the sample of studies and be applied to the population of interest.
Odds ratio
The ratio of two odds of an event from two groups -a treatment or intervention group (a/c) versus a control group (b/d) where a and c represent the number of times the event occurs for the intervention and control group, respectively, using the formula below and the barcoding and comparison practice example table. An OR =1 means the two practices are equally successful (no difference in reducing risk with respect to the outcome evaluated); OR >1 means the barcoding practice is more successful; and OR < 1 means the barcoding practice is less 
Frequencies Proportions
Success Failure Success Failure
Barcoding Practice
Systematic review
A scientific investigation that focuses on a specific question and that uses explicit, planned scientific methods to identify, select, assess, and summarize the findings of similar but separate studies. It may or may not include a quantitative synthesis of the results from separate studies (meta-analysis).
Transparency
Methods are explicitly defined, consistently applied, and available for public review so that observers can readily link judgments, decisions, or actions to the data on which they are based. Allows users to assess the strengths and weaknesses of the systematic review and associated guidance and recommendations. Each box represents the mean odds ratio for an individual study indicated to the far left, with the box size proportional to the study sample size. The endpoints of the lines on the left and right sides of the box represent the lower and upper limits, respectively, of the study odds ratio's 95% confidence interval, with the numerical values provided to the left. The bottom line represents the overall summary effect (or grand mean) for all the studies in the body of evidence along with its confidence interval. In addition, meta-analysis results were tabulated separately for two subgroups using the two study quality ratings "Fair" and "Good. 
